- Filed
- Apr 24, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Nov 27, 2023 | 63.24M sh |
| Shares Diluted | Q2 2024 · Oct 31, 2023 | 63.15M sh |
| Shares Diluted | Q2 2024 · Oct 31, 2023 | 62.99M sh |
| Shares Diluted | Q2 2024 · Oct 31, 2022 | 62.2M sh |
| Shares Diluted restated | Q2 2024 · Oct 31, 2022 | 70.35M sh |
| Capex restated | Q2 2024 · Oct 31, 2023 | $21.62M |
| Capex restated | Q2 2024 · Oct 31, 2022 | $41.28M |
| Operating Cash Flow restated | Q2 2024 · Oct 31, 2023 | $6.01M |
| Operating Cash Flow restated | Q2 2024 · Oct 31, 2022 | −$8.93M |
| Long Term Debt | Q2 2024 · Oct 31, 2023 | $55.54M |
| Cash And Equivalents | Q2 2024 · Oct 31, 2023 | $31.42M |
| Cash And Equivalents | Q2 2024 · Apr 30, 2023 | $38.54M |
| Cash And Equivalents | Q2 2024 · Oct 31, 2022 | $77.29M |
| Cash And Equivalents | Q2 2024 · Apr 30, 2022 | $126.17M |
| Stockholders Equity restated | Q2 2024 · Oct 31, 2023 | $183.33M |
| Stockholders Equity restated | Q2 2024 · Jul 31, 2023 | $190.27M |
| Stockholders Equity restated | Q2 2024 · Apr 30, 2023 | $189.17M |
| Stockholders Equity restated | Q2 2024 · Oct 31, 2022 | $181.63M |
| Stockholders Equity restated | Q2 2024 · Jul 31, 2022 | $178.8M |
| Stockholders Equity | Q2 2024 · Apr 30, 2022 | $174.53M |
| Current Liabilities restated | Q2 2024 · Oct 31, 2023 | $219.28M |
| Current Liabilities restated | Q2 2024 · Apr 30, 2023 | $215.15M |
| Total Liabilities restated | Q2 2024 · Oct 31, 2023 | $272.15M |
| Total Liabilities restated | Q2 2024 · Apr 30, 2023 | $262.4M |
| Current Assets | Q2 2024 · Oct 31, 2023 | $104.21M |
| Current Assets | Q2 2024 · Apr 30, 2023 | $112.45M |
| Total Assets restated | Q2 2024 · Oct 31, 2023 | $455.49M |
| Total Assets restated | Q2 2024 · Apr 30, 2023 | $451.57M |
| Eps Diluted | Q2 2024 · Oct 31, 2023 | −$0.15 |
| Eps Diluted | Q2 2024 · Oct 31, 2023 | −$0.18 |
| Eps Diluted restated | Q2 2024 · Oct 31, 2022 | −$0.01 |
| Eps Diluted restated | Q2 2024 · Oct 31, 2022 | $0.00 |
| Eps Basic | Q2 2024 · Oct 31, 2023 | −$0.15 |
| Eps Basic | Q2 2024 · Oct 31, 2023 | −$0.18 |
| Eps Basic restated | Q2 2024 · Oct 31, 2022 | −$0.01 |
| Eps Basic | Q2 2024 · Oct 31, 2022 | $0.01 |
| Sga Expense | Q2 2024 · Oct 31, 2023 | $6.56M |
| Sga Expense | Q2 2024 · Oct 31, 2023 | $12.82M |
| Sga Expense | Q2 2024 · Oct 31, 2022 | $6.83M |
| Sga Expense | Q2 2024 · Oct 31, 2022 | $13.21M |
| Net Income restated | Q2 2024 · Oct 31, 2023 | −$9.52M |
| Net Income restated | Q2 2024 · Oct 31, 2023 | −$11.64M |
| Net Income restated | Q2 2024 · Oct 31, 2022 | −$520K |
| Net Income restated | Q2 2024 · Oct 31, 2022 | $841K |
| Operating Income | Q2 2024 · Oct 31, 2023 | −$11.22M |
| Operating Income | Q2 2024 · Oct 31, 2023 | −$13.39M |
| Operating Income | Q2 2024 · Oct 31, 2022 | −$2.68M |
| Operating Income | Q2 2024 · Oct 31, 2022 | $51K |
| Gross Profit | Q2 2024 · Oct 31, 2023 | −$4.67M |
| Gross Profit | Q2 2024 · Oct 31, 2023 | −$565K |
| Gross Profit | Q2 2024 · Oct 31, 2022 | $4.15M |
| Gross Profit | Q2 2024 · Oct 31, 2022 | $13.26M |
| Revenue | Q2 2024 · Oct 31, 2023 | $25.4M |
| Revenue | Q2 2024 · Oct 31, 2023 | $63.12M |
| Revenue | Q2 2024 · Oct 31, 2022 | $34.76M |
| Revenue | Q2 2024 · Oct 31, 2022 | $71.45M |